DrugPatentWatch Database Preview

Baxter Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for BAXTER HLTHCARE, and when can generic versions of BAXTER HLTHCARE drugs launch?

BAXTER HLTHCARE has one hundred and ninety-four approved drugs.

There are five US patents protecting BAXTER HLTHCARE drugs. There are two tentative approvals on BAXTER HLTHCARE drugs.

Summary for Baxter Hlthcare

US Patents:	5
Tradenames:	304
Ingredients:	111
NDAs:	194

Drugs and US Patents for Baxter Hlthcare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	CEFTAZIDIME SODIUM IN PLASTIC CONTAINER	ceftazidime sodium	INJECTABLE;INJECTION	063221-001	Apr 29, 1993		DISCN	No	No
Baxter Hlthcare Corp	PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride	INJECTABLE;INJECTION	021703-003	Oct 25, 2006		RX	Yes	Yes
Baxter Hlthcare	DEXTROSE 60% IN PLASTIC CONTAINER	dextrose	INJECTABLE;INJECTION	020047-002	Jul 2, 1991		DISCN	No	No
Baxter Hlthcare Corp	GRANISETRON HYDROCHLORIDE	granisetron hydrochloride	INJECTABLE;INJECTION	078197-001	Dec 31, 2007		DISCN	No	No
Baxter Hlthcare	TRAVASOL 3.5% W/ ELECTROLYTES	amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	017493-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Baxter Hlthcare	ANCEF IN PLASTIC CONTAINER	cefazolin sodium	INJECTABLE;INJECTION	063002-002	Mar 28, 1991		RX	No	Yes

Expired US Patents for Baxter Hlthcare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare	IFEX	ifosfamide	INJECTABLE;INJECTION	019763-001	Dec 30, 1988	4,882,452
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	4,886,789
Baxter Hlthcare	BREVIBLOC IN PLASTIC CONTAINER	esmolol hydrochloride	INJECTABLE;INJECTION	019386-004	Feb 16, 2001	4,593,119*PED
Baxter Hlthcare	FORANE	isoflurane	LIQUID;INHALATION	017624-001	Approved Prior to Jan 1, 1982	3,535,388
Baxter Hlthcare	NEXTERONE	amiodarone hydrochloride	INJECTABLE;INJECTION	022325-001	Dec 24, 2008	5,376,645
Baxter Hlthcare	CYTOXAN (LYOPHILIZED)	cyclophosphamide	INJECTABLE;INJECTION	012142-008	Jan 4, 1984	4,537,883

Paragraph IV (Patent) Challenges for BAXTER HLTHCARE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Injection	10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags		2014-01-31
	Inhalation	99.90%		2008-09-11

Non-Orange Book US Patents for Baxter Hlthcare

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,410,077	Sulfoalkyl ether cyclodextrin compositions
9,750,822	Sulfoalkyl ether cyclodextrin compositions
9,200,088	Sulfoalkyl ether cyclodextrin compositions

International Patents for Baxter Hlthcare Drugs

Country	Document Number	Estimated Expiration
Spain	2378306
Denmark	288586
Japan	S6248701
European Patent Office	1501496
World Intellectual Property Organization (WIPO)	2009134347
Russian Federation	2286774

Supplementary Protection Certificates for Baxter Hlthcare Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0002	France		PRODUCT NAME: MANNITOL; NAT. REGISTRATION NO/DATE: NL 34557 20080819; FIRST REGISTRATION: SE - 22708 20061020
0753	Netherlands		PRODUCT NAME: TRASTUZUMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
C0021	France		PRODUCT NAME: PEGAPTANIB SODIUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131
C/GB97/078	United Kingdom		PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
C0025	Belgium		PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
0612	Netherlands		PRODUCT NAME: 4-AMINOPYRIDINE, DAN WEL EEN DERIVAAT DAARVAN, IN HET BIJZONDER EEN ZOUT, SOLVAAT OF PRODRUG; REGISTRATION NO/DATE: EU/1/11/699/001-002 20110720

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Baxter Hlthcare
• Baxter Hlthcare Corp